Chimeric momp antigen
AssigneeSpixia Biotechnology AB
InventorsSören Andersson, Åke Strid
Life of this patent
Estimating the term…
Abstract
The present invention regards polypeptides capable of eliciting an immunological response that is protective against Chlamydia trachomatis. The polypeptide comprises a first amino acid sequence which has at least 90% homology with the amino acid sequence according to SEQ ID NO: 1 and a second amino acid sequence which has at least 90% homology with the amino acid sequence according to SEQ ID NO: 2. Furthermore, production of these polypeptides and pharmaceutical compositions comprising them are also provided.
Claims30
A polypeptide comprising a first amino acid sequence which has at least 90% homology with the amino acid sequence according to SEQ ID NO:
- 1 and a second amino acid sequence which has at least 90% homology with the amino acid sequence according to SEQ ID NO:
- 2, wherein said first and second amino acid sequences are separated by less than 30 amino acid residues.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.